These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 8872963)

  • 1. Down-regulation of hepatic LDL receptor expression in experimental nephrosis.
    Vaziri ND; Liang KH
    Kidney Int; 1996 Sep; 50(3):887-93. PubMed ID: 8872963
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of PCSK9 and IDOL in the pathogenesis of acquired LDL receptor deficiency and hypercholesterolemia in nephrotic syndrome.
    Liu S; Vaziri ND
    Nephrol Dial Transplant; 2014 Mar; 29(3):538-43. PubMed ID: 24166456
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatic tissue sterol regulatory element binding protein 2 and low-density lipoprotein receptor in nephrotic syndrome.
    Kim CH; Kim HJ; Mitsuhashi M; Vaziri ND
    Metabolism; 2007 Oct; 56(10):1377-82. PubMed ID: 17884448
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acquired VLDL receptor deficiency in experimental nephrosis.
    Liang K; Vaziri ND
    Kidney Int; 1997 Jun; 51(6):1761-5. PubMed ID: 9186864
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatic HMG-CoA reductase gene expression during the course of puromycin-induced nephrosis.
    Vaziri ND; Liang KH
    Kidney Int; 1995 Dec; 48(6):1979-85. PubMed ID: 8587261
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene expression of hepatic cholesterol 7 alpha-hydroxylase in the course of puromycin-induced nephrosis.
    Liang KH; Oveisi F; Vaziri ND
    Kidney Int; 1996 Mar; 49(3):855-60. PubMed ID: 8648930
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Down-regulation of hepatic high-density lipoprotein receptor, SR-B1, in nephrotic syndrome.
    Liang K; Vaziri ND
    Kidney Int; 1999 Aug; 56(2):621-6. PubMed ID: 10432401
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Down-regulation of hepatic lipase expression in experimental nephrotic syndrome.
    Liang K; Vaziri ND
    Kidney Int; 1997 Jun; 51(6):1933-7. PubMed ID: 9186885
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nephrotic syndrome causes upregulation of HDL endocytic receptor and PDZK-1-dependent downregulation of HDL docking receptor.
    Vaziri ND; Gollapudi P; Han S; Farahmand G; Yuan J; Rahimi A; Moradi H
    Nephrol Dial Transplant; 2011 Oct; 26(10):3118-23. PubMed ID: 21459782
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of HMG-CoA reductase inhibition on hepatic expression of key cholesterol-regulatory enzymes and receptors in nephrotic syndrome.
    Vaziri ND; Liang K
    Am J Nephrol; 2004; 24(6):606-13. PubMed ID: 15583480
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acyl-coenzyme A:cholesterol acyltransferase inhibition ameliorates proteinuria, hyperlipidemia, lecithin-cholesterol acyltransferase, SRB-1, and low-denisty lipoprotein receptor deficiencies in nephrotic syndrome.
    Vaziri ND; Liang KH
    Circulation; 2004 Jul; 110(4):419-25. PubMed ID: 15262831
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dietary linoleic acid increases and palmitic acid decreases hepatic LDL receptor protein and mRNA abundance in young pigs.
    Mustad VA; Ellsworth JL; Cooper AD; Kris-Etherton PM; Etherton TD
    J Lipid Res; 1996 Nov; 37(11):2310-23. PubMed ID: 8978483
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Up-regulation of acyl-coenzyme A:cholesterol acyltransferase (ACAT) in nephrotic syndrome.
    Vaziri ND; Liang K
    Kidney Int; 2002 May; 61(5):1769-75. PubMed ID: 11967026
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo regulation of low-density lipoprotein receptors by estrogen differs at the post-transcriptional level in rat and mouse.
    Srivastava RA; Baumann D; Schonfeld G
    Eur J Biochem; 1993 Sep; 216(2):527-38. PubMed ID: 8375391
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A soy protein diet alters hepatic lipid metabolism gene expression and reduces serum lipids and renal fibrogenic cytokines in rats with chronic nephrotic syndrome.
    Tovar AR; Murguía F; Cruz C; Hernández-Pando R; Aguilar-Salinas CA; Pedraza-Chaverri J; Correa-Rotter R; Torres N
    J Nutr; 2002 Sep; 132(9):2562-9. PubMed ID: 12221209
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acquired lecithin-cholesterol acyltransferase deficiency in nephrotic syndrome.
    Vaziri ND; Liang K; Parks JS
    Am J Physiol Renal Physiol; 2001 May; 280(5):F823-8. PubMed ID: 11292624
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Silencing of mouse hepatic lanosterol 14-alpha demethylase down-regulated plasma low-density lipoprotein cholesterol levels by short-term treatment of siRNA.
    Xu B; Wang C; Yang J; Mao G; Zhang C; Liu D; Tai P; Zhou B; Xia G; Zhang M
    Biol Pharm Bull; 2008 Jun; 31(6):1182-91. PubMed ID: 18520052
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Curcumin enhances cell-surface LDLR level and promotes LDL uptake through downregulation of PCSK9 gene expression in HepG2 cells.
    Tai MH; Chen PK; Chen PY; Wu MJ; Ho CT; Yen JH
    Mol Nutr Food Res; 2014 Nov; 58(11):2133-45. PubMed ID: 25164566
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modeling of corticosteroid effects on hepatic low-density lipoprotein receptors and plasma lipid dynamics in rats.
    Hazra A; Pyszczynski NA; DuBois DC; Almon RR; Jusko WJ
    Pharm Res; 2008 Apr; 25(4):769-80. PubMed ID: 17674160
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibitors of 3-hydroxy-3-methylglutaryl coenzyme A reductase unmask transcriptional regulation of hepatic low-density lipoprotein receptor gene expression by dietary cholesterol.
    Lopez D; Ness GC
    Arch Biochem Biophys; 1997 Aug; 344(1):215-9. PubMed ID: 9244400
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.